ENTRY       D04045                      Drug
NAME        Erlizumab (USAN/INN)
EFFICACY    Immunosuppressant, Anti-CD18 antibody
  TYPE      Monoclonal antibody
COMMENT     Adjunctive treatment to reperfusion therapy in acute myocardial infarction or other types of reperfusion therapy
TARGET      ITGB2/ITGAL [HSA:3689 3683] [KO:K06464 K05718]
  PATHWAY   hsa04514(3683+3689)  Cell adhesion molecules
            hsa04650(3683+3689)  Natural killer cell mediated cytotoxicity
            hsa04670(3683+3689)  Leukocyte transendothelial migration
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: other families
               Integrins
                ITGB2/ITGAL
                 D04045  Erlizumab (USAN/INN)
DBLINKS     CAS: 211323-03-4
            PubChem: 47206008
///
